VEGFA and osteosarcoma: On the other hand, osteosarcoma cells may release EVs rich in matrix metalloproteinase (MMP)-1, vascular endothelial growth factor (VEGF), and adhesion molecules, which favor bone remodeling, neoangiogenesis, and metastasis development [54].